loadpatents
name:-0.015156030654907
name:-0.01475715637207
name:-0.0051999092102051
Lehner; Stefan Patent Filings

Lehner; Stefan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lehner; Stefan.The latest application filed is for "method for operating a clutch of a motor vehicle, and motor vehicle".

Company Profile
5.21.18
  • Lehner; Stefan - Ingolstadt DE
  • Lehner; Stefan - Wiesbaden DE
  • Lehner; Stefan - Ingelheim am Rhein N/A DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for operating a clutch of a motor vehicle, and motor vehicle
Grant 11,174,906 - Baer , et al. November 16, 2
2021-11-16
Method For Operating A Clutch Of A Motor Vehicle, And Motor Vehicle
App 20210277965 - BAER; Michael ;   et al.
2021-09-09
Liquid preparation comprising pimobendan
Grant 10,639,305 - Folger , et al.
2020-05-05
Oral suspension comprising telmisartan
Grant 10,537,523 - Mohr , et al. Ja
2020-01-21
Method for operating a drive train for a motor vehicle and corresponding drive train
Grant 10,464,416 - Graf , et al. No
2019-11-05
Oral Suspension Comprising Telmisartan
App 20190247305 - MOHR; Detlef ;   et al.
2019-08-15
Oral suspension comprising telmisartan
Grant 10,314,782 - Mohr , et al.
2019-06-11
Low concentration meloxicam tablets
Grant 10,278,924 - Folger , et al.
2019-05-07
Low concentration meloxicam tablets
Grant 9,943,486 - Folger , et al. April 17, 2
2018-04-17
Method For Operating A Drive Train For A Motor Vehicle And Corresponding Drive Train
App 20180043773 - GRAF; Christian ;   et al.
2018-02-15
Novel Low Concentration Meloxicam Tablets
App 20170367983 - FOLGER; Martin A. ;   et al.
2017-12-28
Low concentration meloxicam tablets
Grant 9,795,568 - Folger , et al. October 24, 2
2017-10-24
Liquid Preparation Comprising Pimobendan
App 20170165260 - FOLGER; Martin ;   et al.
2017-06-15
Liquid preparation comprising pimobendan
Grant 9,616,134 - Folger , et al. April 11, 2
2017-04-11
Taste masked pharmaceutical composition
Grant 9,289,390 - Folger , et al. March 22, 2
2016-03-22
Liquid preparation comprising pimobendan
Grant 9,107,952 - Folger , et al. August 18, 2
2015-08-18
Oral Suspension Comprising Telmisartan
App 20140364473 - Mohr; Detlef ;   et al.
2014-12-11
Pharmaceutical oral telmisartan solution
Grant 8,871,795 - Mohr , et al. October 28, 2
2014-10-28
Kit-of-parts
App 20140224680 - FOLGER; Martin ;   et al.
2014-08-14
Taste Masked Pharmaceutical Composition
App 20140227351 - FOLGER; Martin ;   et al.
2014-08-14
Taste masked pharmaceutical composition
Grant 8,741,350 - Folger , et al. June 3, 2
2014-06-03
Low Concentration Meloxicam Tablets
App 20130195977 - Folger; Martin A. ;   et al.
2013-08-01
Taste Masked Pharmaceutical Composition
App 20130084332 - FOLGER; Martin ;   et al.
2013-04-04
Pharmaceutical Oral Telmisartan Solution
App 20120095069 - Mohr; Detlef ;   et al.
2012-04-19
Novel Low Concentration Meloxicam Tablets
App 20110275618 - FOLGER; Martin A. ;   et al.
2011-11-10
Liquid Preparation Comprising Pimobendan
App 20080207629 - Folger; Martin ;   et al.
2008-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed